A next-generation immune complex vaccine against Gumboro disease with a unique formulation:
TO GUARANTEE THE COMPLETE COATING OF THE IBDV VIRUS
All these improvements ensure the maintenance of the maximum potency and safety of the vaccine with consistent results in the field, even in the presence of varying levels of maternal antibodies.
Your shield against emergent Gumboro threats
VALIDATED SAFETY: for sunny days
The quality controls ensure the correct immune complex creation (unbond IBDV-specific egg antibodies) and avoid a too early replication in the bursas
Lymphocyte depletion due to vaccine replication does not cause immunosuppression (SPC)
No minimum limit of MDA levels to be administered (SPC)
Also registered for layers (EMA)
IMPROVED EFFICACY: for rainy days
Live attenuated IBD virus with a unique strain (HIPRA 1052)
Not neutralized by MDAs: virus stabilized by IgY (anti-IBVD antibodies)
Individual onset of immunity to varying MDA levels, reducing the immunity gap
Its high breakthrough titer confers early bursal colonization and seroconversion
Restriction of emergent field IBDV replication and shedding through competitive exclusion
BENEFITS
WELFARE
Non-invasive method of antibody production (egg-origin IgY)
NO NEED FOR FIELD IBDV REVACCINATION
One dose for a lifetime immunity
HEALTHY FLOCK
Prevention against field viruses
No bursal damage & immunosuppression
Improved productivity when displacing field IBDV
UNIQUE COMBINATION WITH AN IN-OVO COCCIDIOSIS VACCINE
“Mix to Win” with GUMBOHATCH + EVANOVO
HATCHERY VACCINATION BENEFITS
No MDA interference & no calculation of the vaccination day
Individual & precise vaccination
Accurate & faster management
Earlier intake of the vaccine
No water quality dependent